Iovance Biotherapeutics, Inc. (IOVA) Revenue History
Iovance Biotherapeutics, Inc. (IOVA) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | $1.19M |
| 2024-12-31 | $164.07M |
| 2025-12-31 | $263.50M |
How IOVA compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc. | $294.28M |
| VCEL | Vericel Corporation | $276.26M |
| HROW | Harrow Inc Com | $272.30M |
| AKBA | Akebia Therapeutics Inc. | $236.20M |
| CERS | Cerus Corporation | $233.80M |
These are five companies in the same sector as IOVA with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Iovance Biotherapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("IOVA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IOVA | $6.52 | -3.26% | 15.62M |
| 3 | ||||
| 4 | ||||
| 5 |